Matches in Nanopublications for { ?s ?p "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 10 of
10
with 100 items per page.
- assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP344861.RAeTe4Pq1cYb_tNWAb1clZoowgwC1JcY0xcbEjxM_rDSg130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP344861.RAeTe4Pq1cYb_tNWAb1clZoowgwC1JcY0xcbEjxM_rDSg130_provenance.
- NP541386.RAc2YzzS6cyBw7OEF7Fleuazt9BaHMWKxyKsVEtUzQvpA130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541386.RAc2YzzS6cyBw7OEF7Fleuazt9BaHMWKxyKsVEtUzQvpA130_provenance.
- NP345075.RAlnS4lMcp8Q_M1u_SS6jUmtG2ABMCGhrEEKD74yUplBk130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP345075.RAlnS4lMcp8Q_M1u_SS6jUmtG2ABMCGhrEEKD74yUplBk130_provenance.
- NP541378.RAoJbSPWekl0qWbHhb_W8f4OuU0FmKIexABU5BjimUbVg130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541378.RAoJbSPWekl0qWbHhb_W8f4OuU0FmKIexABU5BjimUbVg130_provenance.
- NP541381.RAJpvM1pW5TWI-R3VadMtGJl4fHZaKTvsuyvl695ZNP78130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541381.RAJpvM1pW5TWI-R3VadMtGJl4fHZaKTvsuyvl695ZNP78130_provenance.
- NP541380.RAxCMRPQ_G_SKUFC-PiknSAkceVpHbDv37vBBbyYpYqZI130_assertion description "[They also potently blocked MEK phosphorylation in human thyroid cancer cell lines with either RET/PTC1 (TPC1) or BRAF(V600E) (NPA, ARO, and FRO) mutations.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP541380.RAxCMRPQ_G_SKUFC-PiknSAkceVpHbDv37vBBbyYpYqZI130_provenance.